Suscriptores   Asóciese  
Textos Completos Autorizados
IMPORTANCIA DAS ALTERAÇOES ANTROPOMETRICAS NA DOENÇA HEPATICA GORDUROSA NAO ALCOOLICA (DHGNA)

v-estudie-lo-mejor.gif
Expertos Invitados





IMPORTANCIA DAS ALTERAÇOES ANTROPOMETRICAS NA DOENÇA HEPATICA GORDUROSA NAO ALCOOLICA (DHGNA)

(especial para SIIC © Derechos reservados)
As alterações antropométricas mais freqüentes em pacientes com dhgna são obesidade e distribuição de gordura abdominal. Estas se associam com resistência à insulina e síndrome metabólica e esteato-hepatite. Por isso, índice de massa corporal e circunferência da cintura podem ser úteis para avaliar fatores de risco e prognostico nestes pacientes.
Autor:
Raquel Rocha
Columnista Experto de SIIC

Institución:
Facultad de Medicina de Bahía, Universidad Federal de Bahía

Artículos publicados por Raquel Rocha
Coautor
Raquel Rocha* 
Nutricionista, Faculdade de Medicina da Bahi, Universidade Federal da Bahia, Mestranda*
Aprobación
3 de Febrero, 2006 		Primera edición
9 de Octubre, 2006 		Segunda edición, ampliada y corregida
7 de Junio, 2021

IMPORTANCIA DAS ALTERAÇOES ANTROPOMETRICAS NA DOENÇA HEPATICA GORDUROSA NAO ALCOOLICA (DHGNA)


Artículo completo
(castellano)
Extensión:  +/-2.62 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes
Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Gastroenterología, Nutrición
Relacionadas: Atención Primaria, Epidemiología, Geriatría, Medicina Familiar, Medicina Interna



Comprar este artículo
Extensión: 2.62 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Rocha, R
Bibliografía del artículo
1. WHO. Obesity epidemic puts millions at risk from related diseases, WHO Press Release 46, June 12, 1997.
2. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Annals of Internal Medicine 2000; 132:112-7.
3. Misra A, Vikram, NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003; 19(5):457-66.
4. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004; 23(38):6365-78.
5. Pilz B, Bräsen JH, Schneider W, Luft FC. Obesity and hypertension-induced restrictive cardiomyopathy: a harbinger of things to come. Hypertension 2004; 43(5):911-7.
6. Allen HG, Allen JC, Boyd LC, Alston-Mills, BP. Can anthropometric measurements and diet analysis serve as useful tools to determine risk factors for insulin-resistant diabetes type 2 among white and black Americans? Nutrition 2003; 19(7-8):584-88.
7. Lai SW, Ng KC. Which anthropometric indices best predict metabolic disorders in Taiwan? The Southern Medical Journal 2004; 97(6):578-82.
8. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12(5):1106-10.
9. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47(5):699-713.
10. Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine 2002; 346(16):1221-31.
11. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, Takasaki K, Ludwig J. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Journal of Hepatology 2002; 37(1):154-60.
12. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12(5):1106-10.
13. Méndez-Sánchez N, Motola-Kuba D, Bahena-Aponte J, Chavez-Tapia N, Pichardo-Bahena R, Uribe M. Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report. Annals of Hepatology 2003; 2(4):183-5.
14. Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes & Metabolism 2000; 26:98-106.
15. Scheen AJ, Luyckx FK. Obesity and liver disease. The Journal of Clinical Endocrinology and Metabolism 2002; 16(4):703-16.
16. Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004; 40(4):820-6.
17. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. The American Journal of Gastroenterology 2003; 98(5):960-7.
18. Ioannou GN, Weiss NS, Kowdley KV, Dominitz JA. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroesterology 2003; 125:1053-59.
19. Poonawala S, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000; 32(4):689-92.
20. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002; 35(3):635-8.
21. Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, Gouerou H. Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients. Gastroenterologie Clinique et Biologique 2004; 28(3):272-8.
22. Caldwell SH, Hespenheide EE. Subacute liver failure in obese women. American Journal of Gastroenterology 2002; 97(8):2058-62.
23. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002; 36(1):150-5.
24. Knobler H, Schattner A, Zhornicki T, Malnick SDH, Keter D, Sokolovskaya N, Lurie Y, Bass DD. Fatty liver – an additional and treatable feature of the insulin resistance syndrome. The Quarterly Journal of Medicine 1999; 92: 73-9.
25. Hsieh SD, Yoshinaga H, Muto T, Sakurai Y, Kosaka K. Health risks among Japanese men with moderate body mass index. International Journal of Obesity and Related Metabolic Disorders 2000; 24(3):358-62.
26. Hsiao TJ, Chen JC, Wang JD. Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. International Journal of Obesity and Related Metabolic Disorders 2004; 28(1):167-72.
27. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS. Metabolic significance of nonalcoholic Fatty liver disease in nonobese, nondiabetic adults. Archives of Internal Medicine 2004; 25;164(19):2169-75.
28. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33(6):1358-64.
Título español
 Bibliografía
 Artículo completo
(exclusivo a suscriptores)
 Autoevaluación
  Tema principal en SIIC Data Bases
 Especialidades

  English title
  Abstract
  Key words
Full text
(exclusivo a suscriptores)

Autor 
Artículos
Correspondencia
Patrocinio y reconocimiento
Imprimir esta página
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Acerca de SIIC   Estructura de SIIC   Fuentes informativas  

Sociedad Iberoamericana de Información Científica

Copyright siicsalud© 1997-2024 ISSN siicsalud: 1667-9008
ua31517